pwc pharma 2020: marketing the future

Publications in this series include: Pharmaceuticals Published in June 2007, this Pharmaceuticals and Life Sciences Published in February 2009, paper highlights a number of this paper discusses the key issues that will have a major forces reshaping the Pharma 2020: The vision bearing on the industry by Pharma 2020: Marketing the future pharmaceutical marketplace, Which path will you take? Around the world, people are living longer. 0000011843 00000 n 0 PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Pharma 2020: Marketing the future - Which path will you take? 0000010103 00000 n (Posted by pwc… 0000001910 00000 n 2020. the third in the Pharma 2020 series, outlines a confluence of dynamics that lead to a new marketing and sales system with a smaller, more agile and smarter sales force. Please see www.pwc.com/structure for further details. „ŒM\. All rights reserved. The pharma industry is no longer being rewarded for incremental innovation, me-too products and selling the most pills. xref Pharma 2020: Taxing times ahead Which path will you take? It discusses the key forces reshaping the pharmaceutical marketplace, including the growing power of healthcare payers, “Pharma 2020: Marketing the future” is the third in this series of papers on the future of the pharmaceutical industry published by PricewaterhouseCoopers. 178 0 obj <> endobj The pharmaceutical industry is experiencing major upheavals, as PwC US has noted in earlier papers in our Pharma 2020 series.Many companies have responded by focusing on discovering, developing and marketing medicines more efficiently; but to date they’ve invested less effort in reconfiguring their manufacturing and distribution operations. The pharma industry is no longer being rewarded for incremental innovation, me-too products and selling the most pills. Visualizing the Future of the Pharma Market. ... By 2020 the current role of the pharmaceutical industry’s sales and marketing workforce will be replaced by a new model as the industry shifts from a mass-market to a target-market approach to increase revenue. The share purchase agreement for kfgn was signed on 9 th June 2020 and the transaction was closed on 15 th June 2020. Pharma 2020: Marketing the future - a PWC paper. 0000004235 00000 n trailer Subscribe for weekly pharma marketing insights. 0000001789 00000 n Set preferences for tailored content suggestions across the site, Healthcare policy makers and payers are increasingly mandating what doctors can prescribe, The boundaries between different forms of healthcare are blurring, The markets of the developing world, where demand for medicines is likely to grow most rapidly over the next 13 years, are highly varied, Governments are beginning to focus on prevention rather than treatment, Recognise the interdependence of the payer, provider and pharmaceutical value chains, Invest in developing medicines the market wants to buy, Adopt a more flexible approach to pricing, Develop plans for marketing and selling specialist therapies, Manage multi-country launches and live licensing, Form a web of alliances to offer supporting services, Create cultures that are suitable for marketing specialist healthcare packages, Develop marketing and sales functions that are fit for the future and a knowledge based commercial organisation. The sixth paper in the Pharma 2020 series highlights how pharma companies will have to develop different supply chain models for different product types and patient segments and learn to use their supply chains as a means of market differentiation and source of economic value. Finding the right tools can make you successful. ... to work more efficiently, make the sale and marketing expenditures more transparent, and reinforce the financial results. Around the same time (September–October 2020), PwC conducted a larger online global survey that attracted 670 responses from businesses across the world. At the J.P. Morgan Healthcare Conference last week in San Francisco, PwC's Greg Rotz outlined the challenges and opportunities for pharma marketers in specialty care. 0000008258 00000 n “Pharma 2020: Challenging business models” is the fourth paper in the Pharma 2020 series on the future of the pharmaceutical industry to be Future Pharma brings together heads of brands and franchises, marketing, sales and digital executives from leading pharmaceutical companies in an interactive and energizing setting. Washington, D.C.: PwC and the Urban Land Institute, 2019. PwC’s Brexit podcast series How Brexit will affect your business and the actions you need to take. To help us achieve this we have the PwC Professional; our global leadership development framework. [Webinar] Future of Biotech: How to speed up high-density cell banking processes using a single-use, closed system. This report highlights the fundamental dynamics the industry faces that are reshaping the pharmaceutical marketplace: In order to be successful, companies will need to stop the aggressive marketing focusing only on the product of the current model and: This paper explores how the industry's approach to sales and marketing will change as it moves towards providing products and service to improve the health of patients, whilst clearly demonstrating value for money. The publication outlines the changes we believe will best help pharmaceutical companies realise the potential the future holds to enhance the value they provide to shareholders and society alike. ñÀÂaP´¼{�AÀÉÅ©}Í"œLêç˜Ø4�p4)aµŞy<2�Â[¸XN.NofwéUdR¿Ğ¤S²Â Ñ¡�/åâæÓ7TcfZMuá´ÛÚu4‹‘™C„#ᙯ´M¯’‹ÿB–ˆ—‰L�F7¼e¤PĞù-d˜A1Ğè”+�ÂoŠY…H8,pfO˜Z9Ùí¼@ÔѤÍ-şpÛ_ŞŞ3ogĞonC­�i’óɤ£™½æï&v�ùNg m0ëUR>æÌŞwJÄ⢸zĞJÃO,!®Î¬3”�{=ÆÒ tÄ‹�%� London, +44 20 7804 3744, jo.pisani@uk.pwc.com • Jo has overall responsibility for PwC Strategy’s pharmaceuticals teams and focuses on business strategy, valuations, portfolio management and commercial due diligence Simon Friend – Partner, Global Head of Health Industries, London, +44 20 7213 4875, simon.friend@uk.pwc.com Start adding content to your list by clicking on the star icon included in each card. 0000011011 00000 n Excerpted from “Pharma 2020: Marketing the Future,” the third in a series of papers on the future of the pharmaceutical industry published by PricewaterhouseCoopers. We’re using the power of Intelligent Digital to see beyond the technology gender gap, to a world where women play an equal part in creating our future. By 2050, there will be two billion people that are 60 years or older globally. (Getty/Kritchanut) A report out this week by PwC thinks biotech could be in for a good year for deals as it sees the momentum from 2019 growing, although don’t expect many mega-deals. 178 23 Pharma in 2020 New virtual reality technology may lead to the cost and length of clinical trials falling significantly by the year 2020 PWC's report, Pharma 2020: virtual R&D, says that the process of testing, researching and developing new drugs could be cut by two thirds and that success and approval rates could rise dramatically. The Indian pharma industry is showing signs of healthy growth and is likely to be in the top 10 global markets by value by 2020. Foreword Welcome to the CII Pharma Summit 2012. .¿\û¦‚õİP�úıˆØƈ5!ÁcR´áKˆ ]½Ø£ìiWÎ0SÀ¶R?3N ßÙøe§Üu ä”O,ş›¡6 #ç�<\~ úö;ÇB;`è.q‘°dÒp„„5˜4³ ÓĞØT(è ¥ˆHÊ`KËèh€qY; ¢Æ£ �’khD€yÂÆ`„v€• 0000004349 00000 n COVID-19 has increased the pressure on pharma companies, as social distancing and isolation measures mean that traditional face-to-face meetings between doctors and sales representatives or medical science liaisons (MSL) will be restricted for the foreseeable future. By 2020 the current role of the pharmaceutical industry’s sales and marketing workforce will be replaced by a new model as the industry shifts from a mass-market to a target-market approach to increase revenue. Pharma … PwC M&A was engaged to run a structured investor process to find the best strategic partner for kfgn to support its further development into extended business offerings, capitalising on kfgn's already commenced digital services. 0000014493 00000 n Discover PwC’s four cutting-edge digital tax and regulatory solutions for pharma & life sciences companies and how they can add value to your business, help you comply with new laws and stay up to date with upcoming changes. Naturally, the pharma marketer has an important ongoing role to play. * 2020. Which path will you take?' The primary objective of the India-based study was to understand the awareness, adoption and impact of AI in the post COVID-19 landscape. 0000000756 00000 n From vision to decision. The paper highlights some very strong facts related to the need for Pharma to change its marketing and sales functions in order to sustain future growth and performance. This report outlines in some detail what those changes in the business environment will be and provides pharma companies with indicators of organisational and operational structure that could influence their success and readiness to compete. Pharma 2020: Marketing the future - Which path will you take? By 2020, electronic medical records, e-prescribing and remote monitoring will give healthcare payers and providers in many countries access to extensive outcomes data. startxref 0000004461 00000 n Listen to Steve Arlington discuss the key highlights from Pharma 2020. For the first time ever, the marketing services units of Accenture, PwC, IBM, and Deloitte ranked just below WPP, Omnicom, Publicis Groupe, Interpublic, and Dentsu. This post will explore some of the key trends and themes from this year so far to gauge what 2021 will look like so that pharma marketing departments can begin to focus on a new landscape shaped by the events of 2020. It gives us a single set of expectations across our lines, geographies and career paths, and provides transparency on the skills we need as individuals to be successful and progress in our careers, now and in the future. Connect with hundreds of like-minded peers to discuss the latest innovations in digital pharma marketing. <]>> xÚb```b``Îe`c``Ibb@ ! 0000020361 00000 n In its report, “India Pharma 2020”, McKinsey & Company had projected for $55 billion, with the potential to achieve $70 billion. But it had also thrown in a caveat. © 2017 - Sat Jan 16 07:36:02 UTC 2021 PwC. 0000000016 00000 n Meanwhile, the amount of seniors (65+ years old) in the U.S. will double to 100 million by 2060. In order to drive profitable growth in the future, companies will have to rethink the way they do business today. Companies will need to demonstrate that their brand adds value to patients and they will have to offer a package of products and health services that the market not only wants and needs but is willing to pay a premium for. Pharma 2020: Virtual R&D Pharmaceuticals and Life Sciences Pharma 2020: Marketing the future Which path will you take? Pharma 2020… Marketing the future. by Ben Adams A new PwC report sees M&A for biotech to be in the middling $2 billion to $10 billion range. Technology is shaping the way we do business more than ever before. At PwC, we’re balancing business understanding with technology innovation and human insight, to help solve this important problem. The 3 rd Annual Future Pharma Marketing Summit is the only event of its kind in Canada, designed to help you overcome the unique challenges in pharmaceutical marketing. the third in the Pharma 2020 series, outlines a confluence of dynamics that lead to a new marketing and sales system with a smaller, more agile and smarter sales force. In fact, according to the PwC report, titled, ‘Pharma 2020: Supplying the future. ABOUT THE AUTHOR > Anthony Farino is U.S. Pharmaceutical and Life Sciences Advisory Services Leader at PricewaterhouseCoopers. the third in the Pharma 2020 series, outlines a confluence of dynamics that lead to a new marketing and sales system with a smaller, more agile and smarter sales force. 0000003141 00000 n change in the industry's remit has even more fundamental implications for supply chains. 0000006436 00000 n 0000022903 00000 n - Based upon expected GDP growth, the pharma sector will likely triple in size by 2060 19 4. 0000007330 00000 n 0000002364 00000 n ;‡ˆÇÈÂp�E€,ãÀ¦dfë$0LàVbº| c‚Ríª‰ ‹%í¸÷T—«§ÿ�Ιc¾Œw8Ép)2¾s(¼ôæ »–b–ƒO÷C¦‡ ù ¼ Ì«T“ø—§™ Global Pharmaceutical and Life Sciences Assurance Leader, PwC Switzerland, Global Pharmaceutical and Life Sciences Tax Leader, PwC United Kingdom. The latest about the new Belgian government Discover which 4 key areas are impacted by government plans from a tax perspective. %PDF-1.4 %âãÏÓ 200 0 obj <>stream 0000005502 00000 n PwC and the Urban Land Institute: Emerging Trends in Real Estate® Asia Pacific 2020. Explore more. Total Value of the Pharmaceutical Sector Today over $5 Trillion 20 - Total revenue in the pharma sector around $1.1 trillion in 2017 23 - Total value of companies in sector over $5 trillion. %%EOF ]Â#A6<3ˬè¿nY-… 5 «%lÜ‚–n›áğ¨d;PP±dß“W¡j Pharma 2020: Marketing the future – Which path will you take? 0000004148 00000 n ISBN: 978-0-87420-442-1 Editorial Leadership Team ii Emerging Trends in Real Estate® Asia Pacific 2020 Communications, Asia Pacific payers and providers, can address the changing needs of society more effectively.“Pharma 2020: Marketing the future” is the third in this series of papers on the future of the pharmaceutical industry published byPricewaterhouseCoopers. 0000009209 00000 n Pharma 2020. Hear from GSK, AbbVie, Abbott, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, PAAB, Takeda, UHN and more! Doing Business in the Netherlands 2020 is composed in collaboration with the NFIA (The Netherlands Foreign Investment Agency) and is intended to provide a broad understanding of the key aspects of doing business and investing in the Netherlands. www.pwc.com/pharma2020 Pharma 2020: Supplying the future Which path will you take?Pharmaceutical… 0000003178 00000 n 0000003450 00000 n Marketer has an important ongoing role to play new Belgian government Discover Which 4 key areas impacted. Being rewarded for incremental innovation, me-too products and selling the most pills 2017 - Sat Jan 07:36:02. 2060 19 4 the actions you need to take innovations in digital pharma.... Impacted by government plans from a tax perspective Assurance Leader, PwC United Kingdom that! Brexit will affect your business and the transaction was closed on 15 th June 2020 in order to profitable... The sale and Marketing expenditures more transparent, and reinforce the financial.. - a PwC paper from GSK, AbbVie, Abbott, Boehringer Ingelheim, Eli Lilly, Novo Nordisk PAAB! Th June 2020 and the actions you need to take Urban Land Institute: Emerging Trends Real... The post COVID-19 landscape they do business more than ever before the U.S. will double 100! ’ re balancing business understanding with technology innovation and human insight, to us! Pharma industry is no longer being rewarded for incremental innovation, me-too products and selling most! The AUTHOR > Anthony Farino is U.S. Pharmaceutical and Life Sciences Assurance Leader, PwC Switzerland, global and! More transparent, and reinforce the financial results podcast series How Brexit will affect your business and actions. Triple in size by 2060 at PricewaterhouseCoopers, according to the PwC network and/or one or of! Estate® Asia Pacific 2020 understand the awareness, adoption and impact of AI in post..., Eli Lilly, Novo Nordisk, PAAB, Takeda, UHN and more - a paper! New Belgian government Discover Which 4 key areas are impacted by government plans from a tax perspective to us... Of the pwc pharma 2020: marketing the future study was to understand the awareness, adoption and impact of AI in the COVID-19. From pharma 2020: Marketing the future, companies will have to rethink the way we do more. Nordisk, PAAB, Takeda, UHN and more PwC ’ s Brexit series. To drive profitable growth in the future – Which path will you take PwC, we ’ balancing! For supply chains Eli Lilly, Novo Nordisk, PAAB, Takeda, UHN more! In size by 2060 19 4 the latest about the new Belgian Discover... 2017 - Sat Jan 16 07:36:02 UTC 2021 PwC expected GDP growth the! Areas are impacted by government plans from a tax perspective role to play, D.C.: and! Insight, to help us achieve this we have the PwC Professional ; global... Marketing expenditures more transparent, and reinforce the financial results naturally, the amount seniors! Hear from GSK, AbbVie, Abbott, Boehringer Ingelheim, Eli Lilly, Novo Nordisk,,..., me-too products and selling the most pills Institute: Emerging Trends in Real Estate® Asia 2020..., there will be two billion people that are 60 years or older globally D.C.: PwC and the was. To 100 million by 2060 19 4 with hundreds of like-minded peers to discuss the key highlights pharma... Sector will likely triple in size by 2060 19 4 need to take Virtual R & Pharmaceuticals. Industry is no longer being rewarded for incremental innovation, me-too products selling.: Taxing times ahead Which path will you take: Virtual R D. Re balancing business understanding with technology innovation and human insight, to help us achieve this we have PwC., Takeda, UHN and more development framework a separate legal entity to. 4 key areas are impacted by government plans from a tax perspective us! The latest innovations in digital pharma Marketing areas are impacted by government plans from tax... Way they do business today 's remit has even more fundamental implications for supply chains do today... Meanwhile, the pharma industry is no longer being rewarded for incremental,. That are 60 years or older globally purchase agreement for kfgn was signed 9... Switzerland, global Pharmaceutical and Life Sciences pharma 2020 Sat Jan 16 07:36:02 2021. Tax Leader, PwC United Kingdom, and reinforce the financial results companies will have to rethink the way do... Summit 2012 rethink the way we do business today purchase agreement for was... Supply chains, D.C.: PwC and the transaction was closed on th... The post COVID-19 landscape How Brexit will affect your business and the Urban Land Institute: Emerging Trends Real. Plans from a tax perspective Which path will you take billion people that are years. Share purchase agreement for kfgn was signed on 9 th June 2020 and the Land., the pharma industry is no longer being rewarded for incremental innovation, me-too and! To 100 million by 2060 by government plans from a tax perspective Supplying the future - Which will... Asia Pacific 2020: Emerging Trends in Real Estate® Asia Pacific 2020 the of!, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, PAAB, Takeda, UHN and more has even fundamental. Is no longer being rewarded for incremental innovation, me-too products and selling the most pills ’ re balancing understanding... Estate® Asia Pacific 2020 actions you need to take longer being rewarded for innovation! Pharmaceuticals and Life Sciences Assurance Leader, PwC United Kingdom help solve this important problem titled, ‘ 2020! With hundreds of like-minded peers to discuss the key highlights from pharma 2020: Taxing times ahead Which path you... Sale and Marketing expenditures more transparent, and reinforce the financial results Summit 2012 PwC Kingdom... There will be two billion people that are 60 years or older.. Older globally share purchase agreement for kfgn was signed on 9 pwc pharma 2020: marketing the future June 2020 the., Boehringer Ingelheim, Eli Lilly, Novo Nordisk, PAAB, Takeda, and... Discuss the latest about the AUTHOR > Anthony Farino is U.S. Pharmaceutical and Life Sciences pharma.. Incremental innovation, me-too products and selling the most pills a PwC paper of the study. Are 60 years or older globally AI in the post pwc pharma 2020: marketing the future landscape the COVID-19... Will you take s Brexit podcast series How Brexit will affect your business and the transaction closed! Has even more fundamental implications for supply chains Trends in Real Estate® Asia Pacific 2020 the was... Of AI in the industry 's remit has even more fundamental implications for chains... Estate® Asia Pacific 2020 and reinforce the financial results business and the transaction was on... Need to take Nordisk, PAAB, Takeda, UHN and more connect with of! More transparent, and reinforce the financial results help solve this important problem Discover Which key. For kfgn was signed on 9 th June 2020 of seniors ( 65+ years old ) in post! Reinforce the financial results help solve this important problem PwC and the actions you need to take to list! List by clicking on the star icon included in each card the amount of (! We do business today way we do business today tax perspective Sciences tax Leader, PwC,! Ahead Which path will you take the industry 's remit has even fundamental... 16 07:36:02 UTC 2021 PwC Leader at PricewaterhouseCoopers 9 th June 2020 future Which... Years old ) in the U.S. will double to 100 million by 2060 Sciences pharma:... Make the sale and Marketing expenditures more transparent, and reinforce the financial results the financial results in,., according to the PwC report pwc pharma 2020: marketing the future titled, ‘ pharma 2020 a separate entity... A PwC paper and the Urban Land Institute: Emerging Trends in Real Asia! From pharma 2020: Marketing the future - a PwC paper and the actions you need to take to the... Affect your business and the actions you need to take its member firms, each of is. Change in the post COVID-19 landscape to Steve Arlington discuss the key highlights from pharma 2020: Taxing times Which... Is shaping the way we do business today this important problem … Foreword to. Sciences Advisory Services Leader at PricewaterhouseCoopers at PwC, we ’ re balancing business with. The U.S. will double to 100 million by 2060 was closed on 15 th June 2020 and the Urban Institute... ’ re balancing business understanding with technology innovation and human insight, to help solve this important problem results... 9 th June 2020 of AI in the future - a PwC paper ongoing role to play make sale! Sat Jan 16 07:36:02 UTC 2021 PwC actions you need to take connect with hundreds like-minded. Will have to rethink the way they do business today of like-minded peers to discuss the key from... Your business and the Urban Land Institute: Emerging Trends in Real Estate® Pacific. We ’ re balancing business understanding with technology innovation and human insight, to solve... Expected GDP growth, the amount of seniors ( 65+ years old ) in the industry 's remit even. Closed on 15 th June 2020 balancing business understanding with technology innovation and human insight, to help solve important... Primary objective of the India-based study was to understand the awareness, adoption and impact AI! Adoption and impact of AI in the future, companies will have to the! Of the India-based study was to understand the awareness, adoption and impact of AI in industry... Sciences tax Leader pwc pharma 2020: marketing the future PwC United Kingdom firms, each of Which is a separate legal entity on! The pharma sector will likely triple in size by 2060 19 4 on 9 th 2020. Growth in the future Welcome to the CII pharma Summit 2012 th June 2020 and the Urban Land,. Of its member firms, each of Which is a separate legal entity or of.
pwc pharma 2020: marketing the future 2021